ImmunoGen, Inc. (IMGN) Announces Webcast of Presentation at Upcoming Investor Conference
5/3/2013 7:50:23 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) antibody-drug conjugate (ADC) technology, today announced that Gregory Perry, Executive Vice President and Chief Financial Officer, will present at the upcoming Credit Suisse Antibody Day in New York. The presentation is scheduled for 2:00 pm ET on May 10, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by